CRISPR™ MDCKII cell lines development for bioavailability and DDI assessments
ON-DEMAND By Eurofins Discovery
Join this webinar to hear from Eurofins Discovery on the latest offerings for drug-drug interaction assessments using CRISPR KO/KI MDCKII cell lines